Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Anosmia × Lymphoid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 313 Lymphoma 281 Lymphoma, Follicular 241 Lymphoma, Non-Hodgkin 154 Leukemia 131 Hodgkin Disease 124 Multiple Myeloma 115 Leukemia, Lymphocytic, Chronic, B-Cell 101 Lymphoma, Large B-Cell, Diffuse 99 Leukemia, Myeloid, Acute 84 Neoplasms 75 Lymphoma, Mantle-Cell 63 Burkitt Lymphoma 62 Breast Neoplasms 58 Myelodysplastic Syndromes 56 Lymphoma, T-Cell, Cutaneous 52 Lymphoma, B-Cell, Marginal Zone 52 Myeloproliferative Disorders 47 Motor Activity 45 Mycosis Fungoides 44 Lymphoma, Large-Cell, Immunoblastic 42 Sezary Syndrome 39 Hematologic Neoplasms 39 Dementia 39 Primary Myelofibrosis 37 Neoplasms, Plasma Cell 37 Leukemia, Myeloid, Accelerated Phase 36 Leukemia, Myeloid, Chronic-Phase 35 Congenital Abnormalities 34 Recurrence 33

Interventions

Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04716153 2026-01-20

RE-NEZ-SENS

University Hospital, Montpellier

Phase NA Terminated

LymphoidPlasma cell

Anosmia, Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡